Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis Inc. is projected to experience strong revenue growth in the coming years, with forecasts estimating increases in key revenue streams, including a 24% rise to $43 million and a 25% rise in disposables revenue by FY26E, mainly driven by new system sales and continued catheter utilization. The company reported a significant year-over-year revenue increase of 95% in Q2, reaching $8.8 million, alongside anticipated continued growth in recurring revenues, which are expected to rise to approximately $7 million in Q4 2025. Furthermore, Stereotaxis has achieved critical regulatory advancements for its next-generation products, which are expected to enhance disposable revenue per procedure and boost robotic utilization, contributing positively to its overall financial outlook.

Stereotaxis Inc. has reported operating expenses of $8.6 million, which include $2.6 million in non-cash items, signaling a need for careful financial management given that the adjusted operating expenses have only marginally decreased. Factors impacting the company's performance include delays in product approvals, ongoing supply issues with catheters, and competitive pressures from both manual methods and other robotic platforms, all of which contribute to a uncertain revenue outlook. Additionally, the company is facing a net loss of $3.8 million, along with limited cash runway and the potential need for additional financing, which raises concerns about its path to profitability and overall financial stability.